Market Overview - The A-share market experienced an overall decline on October 31, with the Shanghai Composite Index closing at 3954.79 points, down 0.81%, the Shenzhen Component Index at 13378.21 points, down 1.14%, and the ChiNext Index at 3187.53 points, down 2.31% [2] - The total trading volume in the A-share market was 23501.16 billion yuan, a decrease of 1144.6 billion yuan compared to the previous trading day [2] Capital Flow - The main capital in the A-share market saw a net outflow of 437.44 billion yuan, with an opening net outflow of 120.47 billion yuan and a closing net outflow of 90.52 billion yuan [3] - The CSI 300 index recorded a net outflow of 255.4 billion yuan, while the ChiNext saw a net outflow of 162.56 billion yuan and the STAR Market a net outflow of 57.19 billion yuan [5] Sector Performance - The pharmaceutical and biotechnology sector led with a net inflow of 155.42 billion yuan, marking a 2.72% increase [7] - Other sectors with significant net inflows included media (96.02 billion yuan, up 2.98%), computer (92.13 billion yuan, up 1.81%), food and beverage (38.11 billion yuan, up 1.49%), and retail (25.35 billion yuan, up 1.55%) [8] Institutional Activity - Institutions showed interest in several stocks, with notable net purchases in Zejing Pharmaceutical (206.78 million yuan) and Shutaishen (198.10 million yuan) [11] - Conversely, stocks like Shikong Technology experienced significant net selling by institutions [10] Stock Recommendations - Recent institutional recommendations include China Life Insurance with a target price of 10.40 yuan (23.22% upside), and Shanghai Bank with a target price of 12.02 yuan (26.66% upside) [12]
【31日资金路线图】医药生物板块净流入155亿元居首 龙虎榜机构抢筹多股
证券时报·2025-10-31 10:47